Cellular senescence, triggered by sublethal damage, is characterized by indefinite growth arrest, altered gene expression patterns, and a senescence-associated secretory phenotype.While the accumulation of senescent cells during aging decreases tissue function and promotes many age-related diseases, at present there is no universal marker to detect senescent cells in tissues.Cyclin-dependent kinase inhibitors 2A (p16/CDKN2A) and 1A (p21/CDKN1A) can identify senescent cells, but few studies have examined the numbers of cells expressing these markers in different organs as a function of age.Here, we investigated systematically p16-and p21-positive cells in tissue arrays designed to include normal organs from persons across a broad spectrum of ages.Increased numbers of p21-positive and p16-positive cells with donor age were found in skin (epidermis), pancreas, and kidney, while p16-expressing cells increased in brain cortex, liver, spleen and intestine (colon), and p21-expressing cells increased in skin (dermis).The numbers of cells expressing p16 or p21 in lung did not change with age, and muscle did not appear to have p21-or p16positive cells.In summary, different organs display different levels of the senescent proteins p16 and p21 as a function of age across the human life span.